Veterinary Oncology Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Veterinary Oncology Market Report is Segmented by Treatment Type (Radiotherapy, Surgery, Chemotherapy, and Other Treatment Types), Animal Type (Canine, Feline, and Other Animal Types), Application (Lymphoma Cancer, Mast Cell Cancer, Mammary and Squamous Cell Cancer, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Market Sizes and Forecasts in Value Terms (in USD) for the Above Segments.

Veterinary Oncology Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Veterinary Oncology Market Size

Veterinary Oncology Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.00 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Veterinary Oncology Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Veterinary Oncology Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Veterinary Oncology Market Analysis

The Veterinary Oncology Market is expected to register a CAGR of 5% during the forecast period.

Factors such as the rising prevalence of cancer in animals, increasing investments in research and development in the area of veterinary oncology, and growing veterinary healthcare expenditure are expected to drive market growth.

As the burden of cancer cases in animals increases, the demand for effective and advanced therapeutics for cancer treatment is also expected to rise, driving growth in the market studied. For instance, according to a research study published in Aging and Cancer in February 2022, it was estimated that one in four dogs would be diagnosed with cancer in their lifetime. Cancer is the leading cause of death in pets beyond middle age. Therefore, due to the high prevalence of cancer among animals such as dogs, the demand for therapeutics is expected to increase, driving growth in the market studied.

Moreover, the increasing veterinary healthcare expenditure, growing adoption of pet health insurance, and rising research and development activities for the development of effective therapeutics, coupled with new investments, are further expected to augment the growth of the veterinary oncology market during the forecast period. For instance, in January 2024, the Morris Animal Foundation unveiled its latest cohort of eight grant recipients. These researchers are poised to drive forward the Foundation's mission of enhancing the quality of life for canines battling cancer through innovative research endeavors.

The growing burden of cancer in pets is expected to increase demand for veterinary oncology drugs over the forecast period. For instance, according to Kansas City Veterinary Medical Association’s data in July 2022, purebred dogs were 1.9 times more likely to develop cancer than non-purebred dogs in 2022. Thus, the significant burden of cancer in dogs is expected to boost the market over the forecast period.

Moreover, strategic activities by market players, such as funding initiatives, are expected to contribute to market growth over the forecast period. For instance, in November 2022, UW School of Veterinary Medicine received a grant of USD 75,000 to offer life-saving cancer care to pets and their families. The grant was to be distributed on a first-come, first-served basis of up to USD 4,000 per client. Additionally, in May 2022, Jaguar Health launched the Canine Cancer: Take C.H.A.R.G.E. (Canine Health And Registry Exchange). It is a national canine cancer registry that aims to provide the veterinary community and dog owners with vital incidence and prevalence data to aid in the diagnosis and treatment decisions of canine cancer.

Thus, the growing burden of cancer in pets and strategic initiatives taken by the government and market players are expected to contribute to the segment’s growth over the forecast period. However, the high costs associated with cancer treatment and the lack of awareness about veterinary diseases among pet owners are factors that may restrain the growth of the veterinary oncology market during the forecast period.

Veterinary Oncology Industry Overview

The market is moderately fragmented, with several companies operating. The veterinary oncology market is currently experiencing growing interest in cancer therapeutics, and as a result, major companies are directing their focus toward developing and introducing new products. Some of the prominent players in the market include Elanco, Zoetis, Siemens Healthineers (Varian Medical Systems), and Accuray Incorporated.

Veterinary Oncology Market Leaders

  1. Elanco

  2. Zoetis

  3. Siemens Healthineers (Varian Medical Systems)

  4. Accuray Incorporated

  5. OHC (One Health Company)

  6. *Disclaimer: Major Players sorted in no particular order
Veterinary Oncology Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Veterinary Oncology Market News

  • January 2024: ELIAS Animal Health announced that the US Department of Agriculture’s Center for Veterinary Biologics had determined that the data from the company's ECI-OSA-04 pivotal combined safety and efficacy study demonstrated a reasonable expectation of efficacy, a critical milestone in the licensure pathway in canine cancer.
  • October 2023: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co. Inc., announced that its canonized monoclonal antibody gilvetmab (gil-VET-mab) was now available to veterinary specialists practicing oncology across the United States.

Veterinary Oncology Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Cancer Cases in Animals
    • 4.2.2 Increasing Investments on Research and Development in the Area of Veterinary Oncology
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Cancer Treatment and Procedures
    • 4.3.2 Lack of Awareness About Veterinary Diseases Among Pet Owners
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Treatment Type
    • 5.1.1 Radiotherapy
    • 5.1.2 Surgery
    • 5.1.3 Chemotherapy
    • 5.1.4 Other Treatment Types
  • 5.2 By Animal Type
    • 5.2.1 Canine
    • 5.2.2 Feline
    • 5.2.3 Other Animal Types
  • 5.3 By Application
    • 5.3.1 Lymphoma Cancer
    • 5.3.2 Mast Cell Cancer
    • 5.3.3 Mammary and Squamous Cell Cancer
    • 5.3.4 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Spain
    • 5.4.2.5 Italy
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis Inc.
    • 6.1.2 Elanco
    • 6.1.3 Boehringer Ingelheim International GmbH
    • 6.1.4 PetCure Oncology
    • 6.1.5 Siemens Healthineers (Varian Medical System Inc.)
    • 6.1.6 Morphogenesis Inc.
    • 6.1.7 Accuray Incorporated
    • 6.1.8 Nippon Zenyaku Kogyo Co. Ltd (ZENOAQ)
    • 6.1.9 Regeneus Ltd
    • 6.1.10 OHC (One Health Company)
    • 6.1.11 Karyopharm
    • 6.1.12 AB Science
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Veterinary Oncology Industry Segmentation

As per the scope of the report, cancer therapies are drugs that block the growth and proliferation of cancer by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, and immunotherapy. The report includes revenue for cancer therapies provided to animals.

The veterinary oncology market is segmented by treatment type, animal type, application, and geography. By treatment type, the market is segmented into radiotherapy, surgery, chemotherapy, and other treatment types. By animal type, the market is segmented into canine, feline, and other animal types. By application, the market is segmented into lymphoma cancer, mast cell cancer, mammary and squamous cell cancer, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally.

The report offers the market sizes and forecasts in value (USD) for the above segments.

By Treatment Type Radiotherapy
Surgery
Chemotherapy
Other Treatment Types
By Animal Type Canine
Feline
Other Animal Types
By Application Lymphoma Cancer
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Veterinary Oncology Market Research FAQs

What is the current Veterinary Oncology Market size?

The Veterinary Oncology Market is projected to register a CAGR of 5% during the forecast period (2025-2030)

Who are the key players in Veterinary Oncology Market?

Elanco, Zoetis, Siemens Healthineers (Varian Medical Systems), Accuray Incorporated and OHC (One Health Company) are the major companies operating in the Veterinary Oncology Market.

Which is the fastest growing region in Veterinary Oncology Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Veterinary Oncology Market?

In 2025, the North America accounts for the largest market share in Veterinary Oncology Market.

What years does this Veterinary Oncology Market cover?

The report covers the Veterinary Oncology Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Veterinary Oncology Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Veterinary Oncology Industry Report

Statistics for the 2025 Veterinary Oncology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Oncology analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Veterinary Oncology Market Report Snapshots